Vitamin D receptor activation: clinical outcomes

Area of Science:

• Endocrinology
• Nephrology
• Metabolic Bone Disease

Background:

• Vitamin D is crucial for calcium and phosphate balance, impacting bone metabolism.
• Vitamin D deficiency is prevalent due to poor diet, absorption, or sun exposure, leading to elevated parathyroid hormone and negative bone effects.
• In chronic kidney disease (CKD) patients, vitamin D receptor (VDR) activation deficiency is pronounced, with low 25-(OH) vitamin D levels predicting mortality.

Purpose of the Study:

• To summarize the role of vitamin D in bone metabolism and mortality.
• To highlight the increased prevalence and impact of vitamin D deficiency in CKD.
• To compare the efficacy of different vitamin D treatments in CKD.

Main Methods:

• Review of existing literature on vitamin D, bone metabolism, and mortality.
• Analysis of vitamin D status and its correlation with mortality in CKD populations.
• Comparison of outcomes between vitamin D supplementation, calcitriol, and selective VDR activators.

Main Results:

• Vitamin D supplementation is linked to reduced all-cause mortality in the general population.
• Low 25-(OH) vitamin D levels are an independent predictor of mortality in CKD patients.
• Vitamin D repletion improves survival in CKD; selective VDR activators show promise over calcitriol.

Conclusions:

• Vitamin D plays a vital role in bone health and overall survival.
• Addressing vitamin D deficiency is critical, particularly in CKD patients.
• Selective VDR activators may offer survival benefits and improved safety profiles compared to calcitriol in CKD.